LAMA
Showing 51 - 75 of 358
COPD Trial in Dundee, Kirkcaldy (ICS withdrawal protocol, Standard care)
Suspended
- Chronic Obstructive Pulmonary Disease
- ICS withdrawal protocol
- Standard care
-
Dundee, Perthshire, United Kingdom
- +1 more
Jan 20, 2022
Asthma Trial in Spain (To compare in both treatment arms the percentage of patients controlled at week 52.)
Recruiting
- Asthma
- To compare in both treatment arms the percentage of patients controlled at week 52.
-
Inca, Baleares, Spain
- +16 more
Jun 16, 2023
3TR Asthma Biologics Cohort (ABC) Study
Recruiting
- Severe Asthma
-
Copenhagen, Denmark
- +1 more
Nov 6, 2023
Deep Caries, Reversible Pulpitis, Irreversible Pulpitis Trial in Irbid (Biodentine, Mineral Trioxide Aggregate)
Active, not recruiting
- Deep Caries
- +2 more
- Biodentine
- Mineral Trioxide Aggregate
-
Irbid, JordanDr Lama Awawdeh
Sep 24, 2019
Spiolto® Respimat® Versus Triple Combination Therapy in Everyday
Completed
- Pulmonary Disease, Chronic Obstructive
- Long-acting muscarinic antagonist+ Long-acting beta2 adrenoceptor agonist
- Triple combination of Free or fixed Long-acting muscarinic antagonist+ Long-acting beta2 adrenoceptor agonist + inhalative corticosteroids
-
Bad Sachsa, Germany
- +74 more
Nov 10, 2021
Comparative Effectiveness of COPD Treatments
Completed
- Pulmonary Disease, Chronic Obstructive
- LABA and the LAMA tiotropium (LABA-TIO)
- LABA and an ICS (LABA-ICS)
-
Montreal, CanadaCentre for Clinical Epidemiology, McGill University
Jul 10, 2019
Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency, Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy
Recruiting
- Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency
- +51 more
-
Lakewood, CaliforniaCongenital Muscle Disease International Registry (www.cmdir.org)
Aug 3, 2021
Early Intervention Efficacy in COPD
Completed
- Pulmonary Disease, Chronic Obstructive
-
Nara, JapanNara Medical University
May 24, 2022
Patterns of Chronic Obstructive Pulmonary Disease, Initiating
Completed
- Pulmonary Disease, Chronic Obstructive
- Tiotropium bromide + Olodaterol
- Sp(t)iolto® Respimat®
-
New York, New YorkAETION inc
Nov 12, 2021
Study to Evaluate the Risk of Cardiovascular Endpoints
Completed
- Pulmonary Disease, Chronic Obstructive
- Aclidinium bromide
- Other COPD medication
-
London, United KingdomClinical Practice Research Datalink
Jan 30, 2023
Asthma, Corticosteroid Trial in Incheon (Oral corticosteroids)
Not yet recruiting
- Asthma
- Corticosteroid
- Oral corticosteroids
-
Incheon, Gyeongki, Korea, Republic ofIncheon St. Mary's Hospital
Mar 3, 2023
Disease Activity When Ubrogepant Tablets Are Combined With
Recruiting
- Migraine
-
Bronx, New YorkMontefiore/Albert Einstein
Jan 9, 2023
Real-life After Initation of Treatment With Trixeo
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- BGF (budesonide/glycopyrrolate/formoterol fumarate)
-
Acquaviva delle Fonti, Italy
- +23 more
May 8, 2023
COPD (COPD) Trial in Guelph (BGF MDI HFO 320/14.4/9.6µg, BGF MDI HFA 320/14.4/9.6 µg, Placebo MDI HFA)
Not yet recruiting
- COPD (Chronic Obstructive Pulmonary Disease)
- BGF MDI HFO 320/14.4/9.6μg
- +2 more
-
Guelph, Ontario, CanadaResearch Site
Oct 4, 2023
Management of Perforated Peptic Ulcer
Not yet recruiting
- Perforated Peptic Ulcer
- Repair of perforated peptic ulcer
-
Qinā, EgyptQena Faculty of Medicine, South Valley University Hospitals
Jan 17, 2023
Locally Advanced Cervical Cancer Trial in Amsterdam (lymphatic mapping)
Completed
- Locally Advanced Cervical Cancer
- lymphatic mapping
-
Amsterdam, NetherlandsAmsterdam UMC University of Amsterdam
Feb 17, 2023
COPD (COPD) Trial in Worldwide (Tozorakimab, Placebo)
Recruiting
- Chronic Obstructive Pulmonary Disease (COPD)
- Tozorakimab
- Placebo
-
Mobile, Alabama
- +199 more
Aug 10, 2022
FEV1 and IOS Parameters in Adult Asthma Patients
Not yet recruiting
- Bronchial Hyperreactivity
- No intervention
- (no location specified)
Sep 12, 2023
COPD (COPD) Trial in Worldwide (Tozorakimab, Placebo)
Recruiting
- Chronic Obstructive Pulmonary Disease (COPD)
- Tozorakimab
- Placebo
-
Sheffield, Alabama
- +239 more
Aug 10, 2022
COPD Trial in Beijing, Zhengzhou (LABA based treatment: indacaterol, LAMA based treatment: tiotropium, LABA/ICS based treatment:
Completed
- COPD
- LABA based treatment: indacaterol
- +5 more
-
Beijing, China
- +1 more
Aug 27, 2019
Male Pattern Baldness, Androgenetic Alopecia, Hair Loss/Baldness Trial in Ankara, Istanbul (SAGA-001 (A), SAGA-001 (B))
Recruiting
- Male Pattern Baldness
- +4 more
- SAGA-001 (A)
- SAGA-001 (B)
-
Ankara, Turkey
- +1 more
Aug 4, 2023
Behavioral Assessment of Children, Early Intervention Trial in Beirut (Comprehensive structured parent intervention)
Recruiting
- Behavioral Assessment of Children
- Early Intervention
- Comprehensive structured parent intervention
-
Beirut, Hamra, LebanonAmerican University of Beirut
Feb 17, 2022
Premature, Behavior, Child Trial in Beirut (Music exposure, Silence)
Recruiting
- Premature
- Behavior, Child
- Music exposure
- Silence
-
Beirut, LebanonAmerican University of Beirut
Feb 17, 2022
Lung Transplant; Complications, Primary Graft Dysfunction Trial in Milan (PEEP)
Not yet recruiting
- Lung Transplant; Complications
- Primary Graft Dysfunction
- PEEP
-
Milan, ItalyFondazione IRCCS Ca'Granda - Ospedale Maggiore Policlinico
Jan 11, 2023